nodes	percent_of_prediction	percent_of_DWPC	metapath
Captopril—ABCB1—peripheral nervous system neoplasm	0.407	1	CbGaD
Captopril—ABCB1—Alitretinoin—peripheral nervous system neoplasm	0.0339	0.226	CbGbCtD
Captopril—ABCB1—Topotecan—peripheral nervous system neoplasm	0.0339	0.226	CbGbCtD
Captopril—ABCB1—Dactinomycin—peripheral nervous system neoplasm	0.0235	0.157	CbGbCtD
Captopril—REN—forelimb zeugopod—peripheral nervous system neoplasm	0.0212	0.25	CbGeAlD
Captopril—ABCB1—Vincristine—peripheral nervous system neoplasm	0.0145	0.0964	CbGbCtD
Captopril—ABCB1—Cisplatin—peripheral nervous system neoplasm	0.0135	0.0899	CbGbCtD
Captopril—ABCB1—Etoposide—peripheral nervous system neoplasm	0.0133	0.0884	CbGbCtD
Captopril—REN—arm—peripheral nervous system neoplasm	0.00915	0.108	CbGeAlD
Captopril—ABCB1—Doxorubicin—peripheral nervous system neoplasm	0.00904	0.0603	CbGbCtD
Captopril—ACE—forelimb zeugopod—peripheral nervous system neoplasm	0.00903	0.106	CbGeAlD
Captopril—CYP2D6—Doxorubicin—peripheral nervous system neoplasm	0.00852	0.0568	CbGbCtD
Captopril—F2—forelimb—peripheral nervous system neoplasm	0.00743	0.0875	CbGeAlD
Captopril—REN—nerve—peripheral nervous system neoplasm	0.00583	0.0687	CbGeAlD
Captopril—ACE—forelimb—peripheral nervous system neoplasm	0.00454	0.0535	CbGeAlD
Captopril—ACE—arm—peripheral nervous system neoplasm	0.0039	0.0459	CbGeAlD
Captopril—LTA4H—trigeminal ganglion—peripheral nervous system neoplasm	0.00366	0.0431	CbGeAlD
Captopril—LTA4H—parotid gland—peripheral nervous system neoplasm	0.00345	0.0407	CbGeAlD
Captopril—MMP2—trigeminal ganglion—peripheral nervous system neoplasm	0.0026	0.0306	CbGeAlD
Captopril—REN—brainstem—peripheral nervous system neoplasm	0.0025	0.0295	CbGeAlD
Captopril—ACE—nerve—peripheral nervous system neoplasm	0.00248	0.0293	CbGeAlD
Captopril—ACE—ganglion—peripheral nervous system neoplasm	0.00245	0.0289	CbGeAlD
Captopril—MMP2—parotid gland—peripheral nervous system neoplasm	0.00245	0.0289	CbGeAlD
Captopril—LTA4H—cerebellum—peripheral nervous system neoplasm	0.0016	0.0188	CbGeAlD
Captopril—REN—cerebellum—peripheral nervous system neoplasm	0.00123	0.0145	CbGeAlD
Captopril—CYP2D6—brainstem—peripheral nervous system neoplasm	0.000522	0.00615	CbGeAlD
Captopril—Enalapril—ABCB1—peripheral nervous system neoplasm	0.000516	1	CrCbGaD
Captopril—MMP2—Plasma membrane estrogen receptor signaling—HRAS—peripheral nervous system neoplasm	0.000453	0.00461	CbGpPWpGaD
Captopril—MMP2—Axon guidance—NCAM1—peripheral nervous system neoplasm	0.000445	0.00454	CbGpPWpGaD
Captopril—F2—Angiopoietin receptor Tie2-mediated signaling—PTPN11—peripheral nervous system neoplasm	0.000445	0.00453	CbGpPWpGaD
Captopril—MMP9—Developmental Biology—CNTN6—peripheral nervous system neoplasm	0.000427	0.00435	CbGpPWpGaD
Captopril—ABCB1—trigeminal ganglion—peripheral nervous system neoplasm	0.000424	0.005	CbGeAlD
Captopril—MMP2—Direct p53 effectors—MET—peripheral nervous system neoplasm	0.000417	0.00424	CbGpPWpGaD
Captopril—MMP9—Spinal Cord Injury—BDNF—peripheral nervous system neoplasm	0.000416	0.00424	CbGpPWpGaD
Captopril—REN—Metabolism of proteins—BCHE—peripheral nervous system neoplasm	0.000409	0.00417	CbGpPWpGaD
Captopril—MMP9—Plasma membrane estrogen receptor signaling—NRAS—peripheral nervous system neoplasm	0.000406	0.00413	CbGpPWpGaD
Captopril—MMP9—Angiogenesis—AKT1—peripheral nervous system neoplasm	0.000402	0.0041	CbGpPWpGaD
Captopril—MMP2—Plasma membrane estrogen receptor signaling—AKT1—peripheral nervous system neoplasm	0.0004	0.00407	CbGpPWpGaD
Captopril—MMP2—Degradation of the extracellular matrix—CASP3—peripheral nervous system neoplasm	0.000397	0.00404	CbGpPWpGaD
Captopril—MMP9—CXCR4-mediated signaling events—PTPN11—peripheral nervous system neoplasm	0.00038	0.00387	CbGpPWpGaD
Captopril—F2—Class A/1 (Rhodopsin-like receptors)—NTS—peripheral nervous system neoplasm	0.000375	0.00382	CbGpPWpGaD
Captopril—MMP9—AP-1 transcription factor network—CDKN2A—peripheral nervous system neoplasm	0.000364	0.0037	CbGpPWpGaD
Captopril—MMP9—Extracellular matrix organization—NCAM1—peripheral nervous system neoplasm	0.000344	0.0035	CbGpPWpGaD
Captopril—MMP2—Angiopoietin receptor Tie2-mediated signaling—AKT1—peripheral nervous system neoplasm	0.000341	0.00347	CbGpPWpGaD
Captopril—MMP9—LPA receptor mediated events—CASP3—peripheral nervous system neoplasm	0.000339	0.00345	CbGpPWpGaD
Captopril—MMP2—Regulation of nuclear beta catenin signaling and target gene transcription—MYC—peripheral nervous system neoplasm	0.000338	0.00344	CbGpPWpGaD
Captopril—MMP9—AGE/RAGE pathway—CASP3—peripheral nervous system neoplasm	0.000331	0.00337	CbGpPWpGaD
Captopril—MMP9—Regulation of nuclear beta catenin signaling and target gene transcription—CDKN2A—peripheral nervous system neoplasm	0.000327	0.00333	CbGpPWpGaD
Captopril—MMP2—Developmental Biology—NCAM1—peripheral nervous system neoplasm	0.000318	0.00324	CbGpPWpGaD
Captopril—MMP2—LPA receptor mediated events—HRAS—peripheral nervous system neoplasm	0.000317	0.00323	CbGpPWpGaD
Captopril—LTA4H—Metabolism—ENO2—peripheral nervous system neoplasm	0.000301	0.00307	CbGpPWpGaD
Captopril—MMP9—Plasma membrane estrogen receptor signaling—HRAS—peripheral nervous system neoplasm	0.000297	0.00302	CbGpPWpGaD
Captopril—MMP9—Axon guidance—NCAM1—peripheral nervous system neoplasm	0.000292	0.00297	CbGpPWpGaD
Captopril—F2—GPCR ligand binding—NTS—peripheral nervous system neoplasm	0.000286	0.00291	CbGpPWpGaD
Captopril—MMP2—LPA receptor mediated events—AKT1—peripheral nervous system neoplasm	0.00028	0.00285	CbGpPWpGaD
Captopril—F2—GPCR ligand binding—CD55—peripheral nervous system neoplasm	0.000274	0.00279	CbGpPWpGaD
Captopril—MMP2—AGE/RAGE pathway—AKT1—peripheral nervous system neoplasm	0.000273	0.00278	CbGpPWpGaD
Captopril—MMP9—Plasma membrane estrogen receptor signaling—AKT1—peripheral nervous system neoplasm	0.000262	0.00267	CbGpPWpGaD
Captopril—MMP9—Degradation of the extracellular matrix—CASP3—peripheral nervous system neoplasm	0.00026	0.00265	CbGpPWpGaD
Captopril—F2—Cell surface interactions at the vascular wall—PTPN11—peripheral nervous system neoplasm	0.000257	0.00262	CbGpPWpGaD
Captopril—MMP9—TWEAK Signaling Pathway—AKT1—peripheral nervous system neoplasm	0.000257	0.00262	CbGpPWpGaD
Captopril—CYP2D6—cerebellum—peripheral nervous system neoplasm	0.000257	0.00303	CbGeAlD
Captopril—F2—G alpha (q) signalling events—KNG1—peripheral nervous system neoplasm	0.000255	0.00259	CbGpPWpGaD
Captopril—LTA4H—Metabolism—BCHE—peripheral nervous system neoplasm	0.000255	0.00259	CbGpPWpGaD
Captopril—F2—Peptide ligand-binding receptors—KNG1—peripheral nervous system neoplasm	0.000251	0.00256	CbGpPWpGaD
Captopril—MMP9—Signaling by SCF-KIT—PTPN11—peripheral nervous system neoplasm	0.000251	0.00256	CbGpPWpGaD
Captopril—MMP9—AP-1 transcription factor network—MYC—peripheral nervous system neoplasm	0.000246	0.00251	CbGpPWpGaD
Captopril—LTA4H—Metabolism—SLC2A1—peripheral nervous system neoplasm	0.000243	0.00247	CbGpPWpGaD
Captopril—LTA4H—Metabolism—TH—peripheral nervous system neoplasm	0.000239	0.00244	CbGpPWpGaD
Captopril—MMP2—EPH-Ephrin signaling—HRAS—peripheral nervous system neoplasm	0.000233	0.00237	CbGpPWpGaD
Captopril—F2—Gastrin-CREB signalling pathway via PKC and MAPK—KNG1—peripheral nervous system neoplasm	0.000228	0.00232	CbGpPWpGaD
Captopril—Discomfort—Cisplatin—peripheral nervous system neoplasm	0.000226	0.000871	CcSEcCtD
Captopril—Musculoskeletal discomfort—Vincristine—peripheral nervous system neoplasm	0.000226	0.000871	CcSEcCtD
Captopril—Dermatitis exfoliative—Doxorubicin—peripheral nervous system neoplasm	0.000225	0.000866	CcSEcCtD
Captopril—Dizziness—Tretinoin—peripheral nervous system neoplasm	0.000224	0.000866	CcSEcCtD
Captopril—Dizziness—Isotretinoin—peripheral nervous system neoplasm	0.000224	0.000866	CcSEcCtD
Captopril—Insomnia—Vincristine—peripheral nervous system neoplasm	0.000224	0.000865	CcSEcCtD
Captopril—MMP9—Validated targets of C-MYC transcriptional activation—MYC—peripheral nervous system neoplasm	0.000224	0.00228	CbGpPWpGaD
Captopril—Decreased appetite—Alitretinoin—peripheral nervous system neoplasm	0.000224	0.000863	CcSEcCtD
Captopril—F2—Platelet activation, signaling and aggregation—KNG1—peripheral nervous system neoplasm	0.000223	0.00227	CbGpPWpGaD
Captopril—Paraesthesia—Vincristine—peripheral nervous system neoplasm	0.000223	0.000859	CcSEcCtD
Captopril—Malaise—Etoposide—peripheral nervous system neoplasm	0.000222	0.000856	CcSEcCtD
Captopril—Fatigue—Alitretinoin—peripheral nervous system neoplasm	0.000222	0.000855	CcSEcCtD
Captopril—Dermatitis bullous—Doxorubicin—peripheral nervous system neoplasm	0.000222	0.000855	CcSEcCtD
Captopril—MMP9—Regulation of nuclear beta catenin signaling and target gene transcription—MYC—peripheral nervous system neoplasm	0.000221	0.00225	CbGpPWpGaD
Captopril—ABCB1—HIF-1-alpha transcription factor network—SLC2A1—peripheral nervous system neoplasm	0.000221	0.00225	CbGpPWpGaD
Captopril—Constipation—Alitretinoin—peripheral nervous system neoplasm	0.00022	0.000849	CcSEcCtD
Captopril—F2—Platelet Aggregation (Plug Formation)—AKT1—peripheral nervous system neoplasm	0.00022	0.00224	CbGpPWpGaD
Captopril—Abdominal pain—Dactinomycin—peripheral nervous system neoplasm	0.000219	0.000846	CcSEcCtD
Captopril—Body temperature increased—Dactinomycin—peripheral nervous system neoplasm	0.000219	0.000846	CcSEcCtD
Captopril—Anaphylactic shock—Cisplatin—peripheral nervous system neoplasm	0.000219	0.000845	CcSEcCtD
Captopril—Anaphylactoid reaction—Doxorubicin—peripheral nervous system neoplasm	0.000219	0.000844	CcSEcCtD
Captopril—SLC15A1—SLC-mediated transmembrane transport—SLC2A1—peripheral nervous system neoplasm	0.000219	0.00223	CbGpPWpGaD
Captopril—Cardiac arrest—Epirubicin—peripheral nervous system neoplasm	0.000218	0.00084	CcSEcCtD
Captopril—Vomiting—Topotecan—peripheral nervous system neoplasm	0.000218	0.000839	CcSEcCtD
Captopril—Loss of consciousness—Etoposide—peripheral nervous system neoplasm	0.000216	0.000834	CcSEcCtD
Captopril—Cerebrovascular accident—Doxorubicin—peripheral nervous system neoplasm	0.000216	0.000834	CcSEcCtD
Captopril—Vomiting—Tretinoin—peripheral nervous system neoplasm	0.000216	0.000832	CcSEcCtD
Captopril—Vomiting—Isotretinoin—peripheral nervous system neoplasm	0.000216	0.000832	CcSEcCtD
Captopril—Rash—Topotecan—peripheral nervous system neoplasm	0.000216	0.000832	CcSEcCtD
Captopril—Dermatitis—Topotecan—peripheral nervous system neoplasm	0.000216	0.000831	CcSEcCtD
Captopril—Decreased appetite—Vincristine—peripheral nervous system neoplasm	0.000215	0.000831	CcSEcCtD
Captopril—Ataxia—Epirubicin—peripheral nervous system neoplasm	0.000215	0.000831	CcSEcCtD
Captopril—Cough—Etoposide—peripheral nervous system neoplasm	0.000215	0.000828	CcSEcCtD
Captopril—Thrombocytopenia—Cisplatin—peripheral nervous system neoplasm	0.000215	0.000828	CcSEcCtD
Captopril—Headache—Topotecan—peripheral nervous system neoplasm	0.000214	0.000827	CcSEcCtD
Captopril—Rash—Tretinoin—peripheral nervous system neoplasm	0.000214	0.000826	CcSEcCtD
Captopril—Rash—Isotretinoin—peripheral nervous system neoplasm	0.000214	0.000826	CcSEcCtD
Captopril—Tachycardia—Cisplatin—peripheral nervous system neoplasm	0.000214	0.000825	CcSEcCtD
Captopril—Dermatitis—Tretinoin—peripheral nervous system neoplasm	0.000214	0.000825	CcSEcCtD
Captopril—Dermatitis—Isotretinoin—peripheral nervous system neoplasm	0.000214	0.000825	CcSEcCtD
Captopril—Fatigue—Vincristine—peripheral nervous system neoplasm	0.000214	0.000824	CcSEcCtD
Captopril—Vomiting—Melphalan—peripheral nervous system neoplasm	0.000213	0.000822	CcSEcCtD
Captopril—MMP2—Axon guidance—MET—peripheral nervous system neoplasm	0.000213	0.00217	CbGpPWpGaD
Captopril—Hyponatraemia—Doxorubicin—peripheral nervous system neoplasm	0.000213	0.000821	CcSEcCtD
Captopril—Headache—Tretinoin—peripheral nervous system neoplasm	0.000213	0.00082	CcSEcCtD
Captopril—Headache—Isotretinoin—peripheral nervous system neoplasm	0.000213	0.00082	CcSEcCtD
Captopril—Feeling abnormal—Alitretinoin—peripheral nervous system neoplasm	0.000212	0.000818	CcSEcCtD
Captopril—Constipation—Vincristine—peripheral nervous system neoplasm	0.000212	0.000818	CcSEcCtD
Captopril—Rash—Melphalan—peripheral nervous system neoplasm	0.000211	0.000815	CcSEcCtD
Captopril—Dermatitis—Melphalan—peripheral nervous system neoplasm	0.000211	0.000814	CcSEcCtD
Captopril—Gastrointestinal pain—Alitretinoin—peripheral nervous system neoplasm	0.00021	0.000811	CcSEcCtD
Captopril—MMP9—FGF signaling pathway—AKT1—peripheral nervous system neoplasm	0.00021	0.00214	CbGpPWpGaD
Captopril—SLC15A1—Transmembrane transport of small molecules—COX2—peripheral nervous system neoplasm	0.00021	0.00214	CbGpPWpGaD
Captopril—Chest pain—Etoposide—peripheral nervous system neoplasm	0.000209	0.000808	CcSEcCtD
Captopril—Orthostatic hypotension—Epirubicin—peripheral nervous system neoplasm	0.000209	0.000807	CcSEcCtD
Captopril—Anorexia—Cisplatin—peripheral nervous system neoplasm	0.000209	0.000806	CcSEcCtD
Captopril—MMP9—Developmental Biology—NCAM1—peripheral nervous system neoplasm	0.000209	0.00212	CbGpPWpGaD
Captopril—MMP9—LPA receptor mediated events—HRAS—peripheral nervous system neoplasm	0.000208	0.00212	CbGpPWpGaD
Captopril—MMP9—Spinal Cord Injury—CASP3—peripheral nervous system neoplasm	0.000208	0.00212	CbGpPWpGaD
Captopril—Discomfort—Etoposide—peripheral nervous system neoplasm	0.000207	0.000798	CcSEcCtD
Captopril—Hypotension—Cisplatin—peripheral nervous system neoplasm	0.000205	0.00079	CcSEcCtD
Captopril—Abdominal pain—Alitretinoin—peripheral nervous system neoplasm	0.000203	0.000784	CcSEcCtD
Captopril—Body temperature increased—Alitretinoin—peripheral nervous system neoplasm	0.000203	0.000784	CcSEcCtD
Captopril—MMP2—Metabolism of proteins—BCHE—peripheral nervous system neoplasm	0.000203	0.00207	CbGpPWpGaD
Captopril—Nausea—Topotecan—peripheral nervous system neoplasm	0.000203	0.000784	CcSEcCtD
Captopril—Gastrointestinal pain—Vincristine—peripheral nervous system neoplasm	0.000203	0.000782	CcSEcCtD
Captopril—Confusional state—Etoposide—peripheral nervous system neoplasm	0.000202	0.000781	CcSEcCtD
Captopril—MMP9—AP-1 transcription factor network—TP53—peripheral nervous system neoplasm	0.000202	0.00206	CbGpPWpGaD
Captopril—Muscular weakness—Epirubicin—peripheral nervous system neoplasm	0.000202	0.000779	CcSEcCtD
Captopril—Nausea—Tretinoin—peripheral nervous system neoplasm	0.000202	0.000778	CcSEcCtD
Captopril—Nausea—Isotretinoin—peripheral nervous system neoplasm	0.000202	0.000778	CcSEcCtD
Captopril—Cardiac arrest—Doxorubicin—peripheral nervous system neoplasm	0.000201	0.000777	CcSEcCtD
Captopril—Anaphylactic shock—Etoposide—peripheral nervous system neoplasm	0.000201	0.000775	CcSEcCtD
Captopril—Musculoskeletal discomfort—Cisplatin—peripheral nervous system neoplasm	0.0002	0.00077	CcSEcCtD
Captopril—ALB—Platelet degranulation—KNG1—peripheral nervous system neoplasm	0.000199	0.00203	CbGpPWpGaD
Captopril—Ataxia—Doxorubicin—peripheral nervous system neoplasm	0.000199	0.000769	CcSEcCtD
Captopril—Asthenia—Dactinomycin—peripheral nervous system neoplasm	0.000199	0.000768	CcSEcCtD
Captopril—Nausea—Melphalan—peripheral nervous system neoplasm	0.000199	0.000768	CcSEcCtD
Captopril—MMP9—Signaling by SCF-KIT—ERBB2—peripheral nervous system neoplasm	0.000199	0.00202	CbGpPWpGaD
Captopril—MMP2—Axon guidance—PTPN11—peripheral nervous system neoplasm	0.000197	0.002	CbGpPWpGaD
Captopril—Paraesthesia—Cisplatin—peripheral nervous system neoplasm	0.000197	0.000759	CcSEcCtD
Captopril—Thrombocytopenia—Etoposide—peripheral nervous system neoplasm	0.000197	0.000758	CcSEcCtD
Captopril—Tachycardia—Etoposide—peripheral nervous system neoplasm	0.000196	0.000756	CcSEcCtD
Captopril—Eosinophilia—Epirubicin—peripheral nervous system neoplasm	0.000196	0.000756	CcSEcCtD
Captopril—Abdominal pain—Vincristine—peripheral nervous system neoplasm	0.000196	0.000756	CcSEcCtD
Captopril—Body temperature increased—Vincristine—peripheral nervous system neoplasm	0.000196	0.000756	CcSEcCtD
Captopril—Dyspnoea—Cisplatin—peripheral nervous system neoplasm	0.000195	0.000754	CcSEcCtD
Captopril—LTA4H—Metabolism—GNAS—peripheral nervous system neoplasm	0.000195	0.00199	CbGpPWpGaD
Captopril—Pancreatitis—Epirubicin—peripheral nervous system neoplasm	0.000194	0.000749	CcSEcCtD
Captopril—Orthostatic hypotension—Doxorubicin—peripheral nervous system neoplasm	0.000194	0.000747	CcSEcCtD
Captopril—Angina pectoris—Epirubicin—peripheral nervous system neoplasm	0.000193	0.000744	CcSEcCtD
Captopril—LTA4H—Metabolism—ABCB1—peripheral nervous system neoplasm	0.000192	0.00195	CbGpPWpGaD
Captopril—Anorexia—Etoposide—peripheral nervous system neoplasm	0.000191	0.000738	CcSEcCtD
Captopril—F2—FOXA2 and FOXA3 transcription factor networks—AKT1—peripheral nervous system neoplasm	0.000191	0.00195	CbGpPWpGaD
Captopril—Decreased appetite—Cisplatin—peripheral nervous system neoplasm	0.000191	0.000735	CcSEcCtD
Captopril—ALB—Response to elevated platelet cytosolic Ca2+—KNG1—peripheral nervous system neoplasm	0.00019	0.00193	CbGpPWpGaD
Captopril—Diarrhoea—Dactinomycin—peripheral nervous system neoplasm	0.00019	0.000732	CcSEcCtD
Captopril—Pancytopenia—Epirubicin—peripheral nervous system neoplasm	0.000188	0.000725	CcSEcCtD
Captopril—Hypotension—Etoposide—peripheral nervous system neoplasm	0.000188	0.000724	CcSEcCtD
Captopril—Muscular weakness—Doxorubicin—peripheral nervous system neoplasm	0.000187	0.000721	CcSEcCtD
Captopril—ABCB1—Integrated Pancreatic Cancer Pathway—NME1—peripheral nervous system neoplasm	0.000186	0.00189	CbGpPWpGaD
Captopril—F2—Platelet activation, signaling and aggregation—HGF—peripheral nervous system neoplasm	0.000186	0.00189	CbGpPWpGaD
Captopril—Neutropenia—Epirubicin—peripheral nervous system neoplasm	0.000185	0.000714	CcSEcCtD
Captopril—ABCB1—cerebellum—peripheral nervous system neoplasm	0.000185	0.00218	CbGeAlD
Captopril—Asthenia—Alitretinoin—peripheral nervous system neoplasm	0.000185	0.000712	CcSEcCtD
Captopril—MMP9—Validated targets of C-MYC transcriptional activation—TP53—peripheral nervous system neoplasm	0.000184	0.00187	CbGpPWpGaD
Captopril—MMP9—Endochondral Ossification—AKT1—peripheral nervous system neoplasm	0.000184	0.00187	CbGpPWpGaD
Captopril—MMP9—LPA receptor mediated events—AKT1—peripheral nervous system neoplasm	0.000184	0.00187	CbGpPWpGaD
Captopril—Pollakiuria—Epirubicin—peripheral nervous system neoplasm	0.000183	0.000705	CcSEcCtD
Captopril—ACE—Metabolism of proteins—BCHE—peripheral nervous system neoplasm	0.000183	0.00186	CbGpPWpGaD
Captopril—Pruritus—Alitretinoin—peripheral nervous system neoplasm	0.000182	0.000702	CcSEcCtD
Captopril—Eosinophilia—Doxorubicin—peripheral nervous system neoplasm	0.000181	0.000699	CcSEcCtD
Captopril—Photosensitivity reaction—Epirubicin—peripheral nervous system neoplasm	0.000181	0.000697	CcSEcCtD
Captopril—Feeling abnormal—Cisplatin—peripheral nervous system neoplasm	0.000181	0.000697	CcSEcCtD
Captopril—Paraesthesia—Etoposide—peripheral nervous system neoplasm	0.00018	0.000695	CcSEcCtD
Captopril—Pancreatitis—Doxorubicin—peripheral nervous system neoplasm	0.00018	0.000693	CcSEcCtD
Captopril—MMP9—AGE/RAGE pathway—AKT1—peripheral nervous system neoplasm	0.000179	0.00182	CbGpPWpGaD
Captopril—Weight decreased—Epirubicin—peripheral nervous system neoplasm	0.000179	0.000691	CcSEcCtD
Captopril—Dyspnoea—Etoposide—peripheral nervous system neoplasm	0.000179	0.000691	CcSEcCtD
Captopril—Somnolence—Etoposide—peripheral nervous system neoplasm	0.000179	0.000689	CcSEcCtD
Captopril—Angina pectoris—Doxorubicin—peripheral nervous system neoplasm	0.000178	0.000688	CcSEcCtD
Captopril—Asthenia—Vincristine—peripheral nervous system neoplasm	0.000178	0.000686	CcSEcCtD
Captopril—MMP2—Direct p53 effectors—TP53—peripheral nervous system neoplasm	0.000177	0.0018	CbGpPWpGaD
Captopril—Vomiting—Dactinomycin—peripheral nervous system neoplasm	0.000176	0.00068	CcSEcCtD
Captopril—Diarrhoea—Alitretinoin—peripheral nervous system neoplasm	0.000176	0.000679	CcSEcCtD
Captopril—Stevens-Johnson syndrome—Epirubicin—peripheral nervous system neoplasm	0.000175	0.000675	CcSEcCtD
Captopril—Rash—Dactinomycin—peripheral nervous system neoplasm	0.000175	0.000675	CcSEcCtD
Captopril—Decreased appetite—Etoposide—peripheral nervous system neoplasm	0.000175	0.000673	CcSEcCtD
Captopril—Pancytopenia—Doxorubicin—peripheral nervous system neoplasm	0.000174	0.000671	CcSEcCtD
Captopril—Renal failure—Epirubicin—peripheral nervous system neoplasm	0.000173	0.000669	CcSEcCtD
Captopril—Body temperature increased—Cisplatin—peripheral nervous system neoplasm	0.000173	0.000668	CcSEcCtD
Captopril—Fatigue—Etoposide—peripheral nervous system neoplasm	0.000173	0.000668	CcSEcCtD
Captopril—F2—Angiopoietin receptor Tie2-mediated signaling—AKT1—peripheral nervous system neoplasm	0.000173	0.00176	CbGpPWpGaD
Captopril—Stomatitis—Epirubicin—peripheral nervous system neoplasm	0.000172	0.000664	CcSEcCtD
Captopril—Jaundice—Epirubicin—peripheral nervous system neoplasm	0.000172	0.000664	CcSEcCtD
Captopril—Constipation—Etoposide—peripheral nervous system neoplasm	0.000172	0.000662	CcSEcCtD
Captopril—Neutropenia—Doxorubicin—peripheral nervous system neoplasm	0.000171	0.000661	CcSEcCtD
Captopril—Dizziness—Alitretinoin—peripheral nervous system neoplasm	0.00017	0.000656	CcSEcCtD
Captopril—Diarrhoea—Vincristine—peripheral nervous system neoplasm	0.00017	0.000654	CcSEcCtD
Captopril—Pollakiuria—Doxorubicin—peripheral nervous system neoplasm	0.000169	0.000653	CcSEcCtD
Captopril—F2—Class A/1 (Rhodopsin-like receptors)—KNG1—peripheral nervous system neoplasm	0.000169	0.00172	CbGpPWpGaD
Captopril—Photosensitivity reaction—Doxorubicin—peripheral nervous system neoplasm	0.000167	0.000645	CcSEcCtD
Captopril—MMP2—Extracellular matrix organization—CASP3—peripheral nervous system neoplasm	0.000166	0.00169	CbGpPWpGaD
Captopril—ALB—Platelet degranulation—HGF—peripheral nervous system neoplasm	0.000166	0.00169	CbGpPWpGaD
Captopril—Weight decreased—Doxorubicin—peripheral nervous system neoplasm	0.000166	0.000639	CcSEcCtD
Captopril—Feeling abnormal—Etoposide—peripheral nervous system neoplasm	0.000165	0.000638	CcSEcCtD
Captopril—Nausea—Dactinomycin—peripheral nervous system neoplasm	0.000165	0.000636	CcSEcCtD
Captopril—Agranulocytosis—Epirubicin—peripheral nervous system neoplasm	0.000165	0.000635	CcSEcCtD
Captopril—Gastrointestinal pain—Etoposide—peripheral nervous system neoplasm	0.000164	0.000633	CcSEcCtD
Captopril—Dizziness—Vincristine—peripheral nervous system neoplasm	0.000164	0.000632	CcSEcCtD
Captopril—F2—Folate Metabolism—TP53—peripheral nervous system neoplasm	0.000164	0.00167	CbGpPWpGaD
Captopril—Vomiting—Alitretinoin—peripheral nervous system neoplasm	0.000164	0.000631	CcSEcCtD
Captopril—SLC22A6—SLC-mediated transmembrane transport—SLC2A1—peripheral nervous system neoplasm	0.000162	0.00165	CbGpPWpGaD
Captopril—MMP9—Spinal Cord Injury—MYC—peripheral nervous system neoplasm	0.000162	0.00165	CbGpPWpGaD
Captopril—Rash—Alitretinoin—peripheral nervous system neoplasm	0.000162	0.000626	CcSEcCtD
Captopril—Dermatitis—Alitretinoin—peripheral nervous system neoplasm	0.000162	0.000625	CcSEcCtD
Captopril—Stevens-Johnson syndrome—Doxorubicin—peripheral nervous system neoplasm	0.000162	0.000624	CcSEcCtD
Captopril—F2—GPCR downstream signaling—NTS—peripheral nervous system neoplasm	0.000162	0.00164	CbGpPWpGaD
Captopril—Headache—Alitretinoin—peripheral nervous system neoplasm	0.000161	0.000622	CcSEcCtD
Captopril—Renal failure—Doxorubicin—peripheral nervous system neoplasm	0.000161	0.000619	CcSEcCtD
Captopril—Stomatitis—Doxorubicin—peripheral nervous system neoplasm	0.000159	0.000614	CcSEcCtD
Captopril—Jaundice—Doxorubicin—peripheral nervous system neoplasm	0.000159	0.000614	CcSEcCtD
Captopril—Rhinitis—Epirubicin—peripheral nervous system neoplasm	0.000159	0.000613	CcSEcCtD
Captopril—Abdominal pain—Etoposide—peripheral nervous system neoplasm	0.000159	0.000612	CcSEcCtD
Captopril—Body temperature increased—Etoposide—peripheral nervous system neoplasm	0.000159	0.000612	CcSEcCtD
Captopril—Hepatitis—Epirubicin—peripheral nervous system neoplasm	0.000158	0.000611	CcSEcCtD
Captopril—ALB—Response to elevated platelet cytosolic Ca2+—HGF—peripheral nervous system neoplasm	0.000158	0.00161	CbGpPWpGaD
Captopril—Vomiting—Vincristine—peripheral nervous system neoplasm	0.000158	0.000608	CcSEcCtD
Captopril—Asthenia—Cisplatin—peripheral nervous system neoplasm	0.000157	0.000607	CcSEcCtD
Captopril—Pharyngitis—Epirubicin—peripheral nervous system neoplasm	0.000157	0.000607	CcSEcCtD
Captopril—Rash—Vincristine—peripheral nervous system neoplasm	0.000156	0.000603	CcSEcCtD
Captopril—Dermatitis—Vincristine—peripheral nervous system neoplasm	0.000156	0.000602	CcSEcCtD
Captopril—SLC22A6—Transmembrane transport of small molecules—COX2—peripheral nervous system neoplasm	0.000156	0.00159	CbGpPWpGaD
Captopril—MMP2—Axon guidance—ERBB2—peripheral nervous system neoplasm	0.000156	0.00158	CbGpPWpGaD
Captopril—Headache—Vincristine—peripheral nervous system neoplasm	0.000155	0.000599	CcSEcCtD
Captopril—F2—Cell surface interactions at the vascular wall—NRAS—peripheral nervous system neoplasm	0.000155	0.00158	CbGpPWpGaD
Captopril—MMP9—EPH-Ephrin signaling—HRAS—peripheral nervous system neoplasm	0.000153	0.00156	CbGpPWpGaD
Captopril—Nausea—Alitretinoin—peripheral nervous system neoplasm	0.000153	0.000589	CcSEcCtD
Captopril—Agranulocytosis—Doxorubicin—peripheral nervous system neoplasm	0.000152	0.000588	CcSEcCtD
Captopril—MMP2—Developmental Biology—MET—peripheral nervous system neoplasm	0.000152	0.00155	CbGpPWpGaD
Captopril—MMP9—Signaling by SCF-KIT—NRAS—peripheral nervous system neoplasm	0.000151	0.00154	CbGpPWpGaD
Captopril—Diarrhoea—Cisplatin—peripheral nervous system neoplasm	0.00015	0.000578	CcSEcCtD
Captopril—Erythema multiforme—Epirubicin—peripheral nervous system neoplasm	0.00015	0.000578	CcSEcCtD
Captopril—MMP9—CXCR4-mediated signaling events—AKT1—peripheral nervous system neoplasm	0.000148	0.0015	CbGpPWpGaD
Captopril—Nausea—Vincristine—peripheral nervous system neoplasm	0.000147	0.000568	CcSEcCtD
Captopril—Flushing—Epirubicin—peripheral nervous system neoplasm	0.000147	0.000567	CcSEcCtD
Captopril—Rhinitis—Doxorubicin—peripheral nervous system neoplasm	0.000147	0.000567	CcSEcCtD
Captopril—F2—Signaling by GPCR—NTS—peripheral nervous system neoplasm	0.000147	0.00149	CbGpPWpGaD
Captopril—Hepatitis—Doxorubicin—peripheral nervous system neoplasm	0.000147	0.000565	CcSEcCtD
Captopril—Pharyngitis—Doxorubicin—peripheral nervous system neoplasm	0.000145	0.000561	CcSEcCtD
Captopril—Asthenia—Etoposide—peripheral nervous system neoplasm	0.000144	0.000556	CcSEcCtD
Captopril—Pruritus—Etoposide—peripheral nervous system neoplasm	0.000142	0.000548	CcSEcCtD
Captopril—F2—Signaling by GPCR—CD55—peripheral nervous system neoplasm	0.000141	0.00143	CbGpPWpGaD
Captopril—MMP2—Developmental Biology—PTPN11—peripheral nervous system neoplasm	0.000141	0.00143	CbGpPWpGaD
Captopril—Alopecia—Epirubicin—peripheral nervous system neoplasm	0.00014	0.00054	CcSEcCtD
Captopril—MMP9—Axon guidance—MET—peripheral nervous system neoplasm	0.00014	0.00142	CbGpPWpGaD
Captopril—Vomiting—Cisplatin—peripheral nervous system neoplasm	0.000139	0.000538	CcSEcCtD
Captopril—Erythema multiforme—Doxorubicin—peripheral nervous system neoplasm	0.000139	0.000535	CcSEcCtD
Captopril—F2—Gastrin-CREB signalling pathway via PKC and MAPK—PTPN11—peripheral nervous system neoplasm	0.000138	0.00141	CbGpPWpGaD
Captopril—Rash—Cisplatin—peripheral nervous system neoplasm	0.000138	0.000533	CcSEcCtD
Captopril—Dermatitis—Cisplatin—peripheral nervous system neoplasm	0.000138	0.000533	CcSEcCtD
Captopril—Diarrhoea—Etoposide—peripheral nervous system neoplasm	0.000137	0.00053	CcSEcCtD
Captopril—Flushing—Doxorubicin—peripheral nervous system neoplasm	0.000136	0.000525	CcSEcCtD
Captopril—Tension—Epirubicin—peripheral nervous system neoplasm	0.000135	0.000522	CcSEcCtD
Captopril—Dysgeusia—Epirubicin—peripheral nervous system neoplasm	0.000135	0.000521	CcSEcCtD
Captopril—Nervousness—Epirubicin—peripheral nervous system neoplasm	0.000134	0.000517	CcSEcCtD
Captopril—MMP9—Spinal Cord Injury—TP53—peripheral nervous system neoplasm	0.000133	0.00136	CbGpPWpGaD
Captopril—Dizziness—Etoposide—peripheral nervous system neoplasm	0.000133	0.000512	CcSEcCtD
Captopril—Nausea—Cisplatin—peripheral nervous system neoplasm	0.00013	0.000502	CcSEcCtD
Captopril—Vision blurred—Epirubicin—peripheral nervous system neoplasm	0.00013	0.000501	CcSEcCtD
Captopril—Alopecia—Doxorubicin—peripheral nervous system neoplasm	0.00013	0.0005	CcSEcCtD
Captopril—MMP9—Axon guidance—PTPN11—peripheral nervous system neoplasm	0.000129	0.00131	CbGpPWpGaD
Captopril—F2—GPCR ligand binding—KNG1—peripheral nervous system neoplasm	0.000128	0.00131	CbGpPWpGaD
Captopril—Ill-defined disorder—Epirubicin—peripheral nervous system neoplasm	0.000128	0.000494	CcSEcCtD
Captopril—ALB—Metabolism of lipids and lipoproteins—HSD17B12—peripheral nervous system neoplasm	0.000128	0.0013	CbGpPWpGaD
Captopril—Vomiting—Etoposide—peripheral nervous system neoplasm	0.000128	0.000492	CcSEcCtD
Captopril—Anaemia—Epirubicin—peripheral nervous system neoplasm	0.000127	0.000492	CcSEcCtD
Captopril—Rash—Etoposide—peripheral nervous system neoplasm	0.000127	0.000488	CcSEcCtD
Captopril—Dermatitis—Etoposide—peripheral nervous system neoplasm	0.000126	0.000488	CcSEcCtD
Captopril—Headache—Etoposide—peripheral nervous system neoplasm	0.000126	0.000485	CcSEcCtD
Captopril—Tension—Doxorubicin—peripheral nervous system neoplasm	0.000125	0.000483	CcSEcCtD
Captopril—Dysgeusia—Doxorubicin—peripheral nervous system neoplasm	0.000125	0.000482	CcSEcCtD
Captopril—Malaise—Epirubicin—peripheral nervous system neoplasm	0.000124	0.00048	CcSEcCtD
Captopril—Nervousness—Doxorubicin—peripheral nervous system neoplasm	0.000124	0.000478	CcSEcCtD
Captopril—F2—Hemostasis—IFNB1—peripheral nervous system neoplasm	0.000124	0.00126	CbGpPWpGaD
Captopril—Syncope—Epirubicin—peripheral nervous system neoplasm	0.000124	0.000477	CcSEcCtD
Captopril—F2—GPCR downstream signaling—VIP—peripheral nervous system neoplasm	0.000122	0.00125	CbGpPWpGaD
Captopril—Palpitations—Epirubicin—peripheral nervous system neoplasm	0.000122	0.00047	CcSEcCtD
Captopril—Loss of consciousness—Epirubicin—peripheral nervous system neoplasm	0.000121	0.000468	CcSEcCtD
Captopril—Cough—Epirubicin—peripheral nervous system neoplasm	0.00012	0.000464	CcSEcCtD
Captopril—Vision blurred—Doxorubicin—peripheral nervous system neoplasm	0.00012	0.000464	CcSEcCtD
Captopril—Nausea—Etoposide—peripheral nervous system neoplasm	0.000119	0.00046	CcSEcCtD
Captopril—Ill-defined disorder—Doxorubicin—peripheral nervous system neoplasm	0.000118	0.000457	CcSEcCtD
Captopril—MMP2—Axon guidance—NRAS—peripheral nervous system neoplasm	0.000118	0.00121	CbGpPWpGaD
Captopril—Anaemia—Doxorubicin—peripheral nervous system neoplasm	0.000118	0.000455	CcSEcCtD
Captopril—Myalgia—Epirubicin—peripheral nervous system neoplasm	0.000117	0.000453	CcSEcCtD
Captopril—Arthralgia—Epirubicin—peripheral nervous system neoplasm	0.000117	0.000453	CcSEcCtD
Captopril—Chest pain—Epirubicin—peripheral nervous system neoplasm	0.000117	0.000453	CcSEcCtD
Captopril—Discomfort—Epirubicin—peripheral nervous system neoplasm	0.000116	0.000447	CcSEcCtD
Captopril—Malaise—Doxorubicin—peripheral nervous system neoplasm	0.000115	0.000444	CcSEcCtD
Captopril—F2—Hemostasis—KNG1—peripheral nervous system neoplasm	0.000115	0.00117	CbGpPWpGaD
Captopril—Dry mouth—Epirubicin—peripheral nervous system neoplasm	0.000115	0.000443	CcSEcCtD
Captopril—Syncope—Doxorubicin—peripheral nervous system neoplasm	0.000114	0.000441	CcSEcCtD
Captopril—Confusional state—Epirubicin—peripheral nervous system neoplasm	0.000113	0.000438	CcSEcCtD
Captopril—F2—Cell surface interactions at the vascular wall—HRAS—peripheral nervous system neoplasm	0.000113	0.00115	CbGpPWpGaD
Captopril—Palpitations—Doxorubicin—peripheral nervous system neoplasm	0.000113	0.000435	CcSEcCtD
Captopril—Anaphylactic shock—Epirubicin—peripheral nervous system neoplasm	0.000113	0.000434	CcSEcCtD
Captopril—F2—GPCR ligand binding—GNAS—peripheral nervous system neoplasm	0.000112	0.00114	CbGpPWpGaD
Captopril—MMP9—Signaling Pathways—NTS—peripheral nervous system neoplasm	0.000112	0.00114	CbGpPWpGaD
Captopril—Loss of consciousness—Doxorubicin—peripheral nervous system neoplasm	0.000112	0.000433	CcSEcCtD
Captopril—F2—Regulation of Actin Cytoskeleton—NRAS—peripheral nervous system neoplasm	0.000112	0.00114	CbGpPWpGaD
Captopril—Cough—Doxorubicin—peripheral nervous system neoplasm	0.000111	0.00043	CcSEcCtD
Captopril—F2—Signaling by GPCR—VIP—peripheral nervous system neoplasm	0.000111	0.00113	CbGpPWpGaD
Captopril—SLC15A1—Transmembrane transport of small molecules—SLC2A1—peripheral nervous system neoplasm	0.000111	0.00113	CbGpPWpGaD
Captopril—MMP2—Developmental Biology—ERBB2—peripheral nervous system neoplasm	0.000111	0.00113	CbGpPWpGaD
Captopril—Shock—Epirubicin—peripheral nervous system neoplasm	0.000111	0.000427	CcSEcCtD
Captopril—MMP9—Signaling by SCF-KIT—HRAS—peripheral nervous system neoplasm	0.000111	0.00113	CbGpPWpGaD
Captopril—Thrombocytopenia—Epirubicin—peripheral nervous system neoplasm	0.00011	0.000425	CcSEcCtD
Captopril—Tachycardia—Epirubicin—peripheral nervous system neoplasm	0.00011	0.000424	CcSEcCtD
Captopril—MMP9—Extracellular matrix organization—CASP3—peripheral nervous system neoplasm	0.000109	0.00111	CbGpPWpGaD
Captopril—Arthralgia—Doxorubicin—peripheral nervous system neoplasm	0.000109	0.000419	CcSEcCtD
Captopril—Chest pain—Doxorubicin—peripheral nervous system neoplasm	0.000109	0.000419	CcSEcCtD
Captopril—Myalgia—Doxorubicin—peripheral nervous system neoplasm	0.000109	0.000419	CcSEcCtD
Captopril—MMP9—Signaling Pathways—CD55—peripheral nervous system neoplasm	0.000108	0.0011	CbGpPWpGaD
Captopril—Discomfort—Doxorubicin—peripheral nervous system neoplasm	0.000107	0.000414	CcSEcCtD
Captopril—Anorexia—Epirubicin—peripheral nervous system neoplasm	0.000107	0.000414	CcSEcCtD
Captopril—Dry mouth—Doxorubicin—peripheral nervous system neoplasm	0.000106	0.00041	CcSEcCtD
Captopril—Hypotension—Epirubicin—peripheral nervous system neoplasm	0.000105	0.000406	CcSEcCtD
Captopril—Confusional state—Doxorubicin—peripheral nervous system neoplasm	0.000105	0.000405	CcSEcCtD
Captopril—Anaphylactic shock—Doxorubicin—peripheral nervous system neoplasm	0.000104	0.000402	CcSEcCtD
Captopril—F2—Metabolism of proteins—BCHE—peripheral nervous system neoplasm	0.000103	0.00105	CbGpPWpGaD
Captopril—F2—Signaling by GPCR—PPP3R1—peripheral nervous system neoplasm	0.000103	0.00104	CbGpPWpGaD
Captopril—Musculoskeletal discomfort—Epirubicin—peripheral nervous system neoplasm	0.000103	0.000396	CcSEcCtD
Captopril—Shock—Doxorubicin—peripheral nervous system neoplasm	0.000102	0.000395	CcSEcCtD
Captopril—MMP9—Axon guidance—ERBB2—peripheral nervous system neoplasm	0.000102	0.00104	CbGpPWpGaD
Captopril—Thrombocytopenia—Doxorubicin—peripheral nervous system neoplasm	0.000102	0.000393	CcSEcCtD
Captopril—Insomnia—Epirubicin—peripheral nervous system neoplasm	0.000102	0.000393	CcSEcCtD
Captopril—Tachycardia—Doxorubicin—peripheral nervous system neoplasm	0.000102	0.000392	CcSEcCtD
Captopril—Paraesthesia—Epirubicin—peripheral nervous system neoplasm	0.000101	0.00039	CcSEcCtD
Captopril—F2—Hemostasis—GNAS—peripheral nervous system neoplasm	0.0001	0.00102	CbGpPWpGaD
Captopril—Dyspnoea—Epirubicin—peripheral nervous system neoplasm	0.0001	0.000387	CcSEcCtD
Captopril—Somnolence—Epirubicin—peripheral nervous system neoplasm	0.0001	0.000386	CcSEcCtD
Captopril—MMP9—Developmental Biology—MET—peripheral nervous system neoplasm	9.97e-05	0.00101	CbGpPWpGaD
Captopril—Anorexia—Doxorubicin—peripheral nervous system neoplasm	9.93e-05	0.000383	CcSEcCtD
Captopril—Dyspepsia—Epirubicin—peripheral nervous system neoplasm	9.91e-05	0.000382	CcSEcCtD
Captopril—Decreased appetite—Epirubicin—peripheral nervous system neoplasm	9.79e-05	0.000377	CcSEcCtD
Captopril—MMP9—Signaling by SCF-KIT—AKT1—peripheral nervous system neoplasm	9.76e-05	0.000994	CbGpPWpGaD
Captopril—Hypotension—Doxorubicin—peripheral nervous system neoplasm	9.73e-05	0.000375	CcSEcCtD
Captopril—Fatigue—Epirubicin—peripheral nervous system neoplasm	9.7e-05	0.000374	CcSEcCtD
Captopril—Constipation—Epirubicin—peripheral nervous system neoplasm	9.63e-05	0.000371	CcSEcCtD
Captopril—F2—Hemostasis—HGF—peripheral nervous system neoplasm	9.57e-05	0.000974	CbGpPWpGaD
Captopril—Musculoskeletal discomfort—Doxorubicin—peripheral nervous system neoplasm	9.49e-05	0.000366	CcSEcCtD
Captopril—Insomnia—Doxorubicin—peripheral nervous system neoplasm	9.42e-05	0.000363	CcSEcCtD
Captopril—Paraesthesia—Doxorubicin—peripheral nervous system neoplasm	9.35e-05	0.000361	CcSEcCtD
Captopril—Dyspnoea—Doxorubicin—peripheral nervous system neoplasm	9.29e-05	0.000358	CcSEcCtD
Captopril—Feeling abnormal—Epirubicin—peripheral nervous system neoplasm	9.28e-05	0.000358	CcSEcCtD
Captopril—Somnolence—Doxorubicin—peripheral nervous system neoplasm	9.26e-05	0.000357	CcSEcCtD
Captopril—MMP9—Developmental Biology—PTPN11—peripheral nervous system neoplasm	9.22e-05	0.000938	CbGpPWpGaD
Captopril—Gastrointestinal pain—Epirubicin—peripheral nervous system neoplasm	9.2e-05	0.000355	CcSEcCtD
Captopril—Dyspepsia—Doxorubicin—peripheral nervous system neoplasm	9.17e-05	0.000354	CcSEcCtD
Captopril—ABCB1—Integrated Pancreatic Cancer Pathway—CHEK2—peripheral nervous system neoplasm	9.1e-05	0.000927	CbGpPWpGaD
Captopril—Decreased appetite—Doxorubicin—peripheral nervous system neoplasm	9.05e-05	0.000349	CcSEcCtD
Captopril—Fatigue—Doxorubicin—peripheral nervous system neoplasm	8.98e-05	0.000346	CcSEcCtD
Captopril—SLC15A1—Transmembrane transport of small molecules—GNAS—peripheral nervous system neoplasm	8.94e-05	0.00091	CbGpPWpGaD
Captopril—Constipation—Doxorubicin—peripheral nervous system neoplasm	8.91e-05	0.000344	CcSEcCtD
Captopril—Abdominal pain—Epirubicin—peripheral nervous system neoplasm	8.9e-05	0.000343	CcSEcCtD
Captopril—Body temperature increased—Epirubicin—peripheral nervous system neoplasm	8.9e-05	0.000343	CcSEcCtD
Captopril—ALB—Platelet activation, signaling and aggregation—KNG1—peripheral nervous system neoplasm	8.84e-05	0.0009	CbGpPWpGaD
Captopril—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—MYC—peripheral nervous system neoplasm	8.8e-05	0.000896	CbGpPWpGaD
Captopril—SLC15A1—Transmembrane transport of small molecules—ABCB1—peripheral nervous system neoplasm	8.77e-05	0.000893	CbGpPWpGaD
Captopril—F2—Signaling Pathways—NTS—peripheral nervous system neoplasm	8.67e-05	0.000882	CbGpPWpGaD
Captopril—MMP2—Axon guidance—HRAS—peripheral nervous system neoplasm	8.66e-05	0.000882	CbGpPWpGaD
Captopril—Feeling abnormal—Doxorubicin—peripheral nervous system neoplasm	8.58e-05	0.000331	CcSEcCtD
Captopril—Gastrointestinal pain—Doxorubicin—peripheral nervous system neoplasm	8.52e-05	0.000328	CcSEcCtD
Captopril—MMP9—Signaling Pathways—VIP—peripheral nervous system neoplasm	8.51e-05	0.000866	CbGpPWpGaD
Captopril—MMP2—Developmental Biology—NRAS—peripheral nervous system neoplasm	8.45e-05	0.00086	CbGpPWpGaD
Captopril—ALB—SLC-mediated transmembrane transport—SLC2A1—peripheral nervous system neoplasm	8.44e-05	0.000859	CbGpPWpGaD
Captopril—ALB—Metabolism—PPIP5K2—peripheral nervous system neoplasm	8.42e-05	0.000857	CbGpPWpGaD
Captopril—F2—Gastrin-CREB signalling pathway via PKC and MAPK—NRAS—peripheral nervous system neoplasm	8.32e-05	0.000847	CbGpPWpGaD
Captopril—F2—Signaling Pathways—CD55—peripheral nervous system neoplasm	8.31e-05	0.000846	CbGpPWpGaD
Captopril—ABCB1—Integrated Pancreatic Cancer Pathway—NTRK1—peripheral nervous system neoplasm	8.3e-05	0.000845	CbGpPWpGaD
Captopril—SLC22A6—Transmembrane transport of small molecules—SLC2A1—peripheral nervous system neoplasm	8.25e-05	0.00084	CbGpPWpGaD
Captopril—Abdominal pain—Doxorubicin—peripheral nervous system neoplasm	8.23e-05	0.000318	CcSEcCtD
Captopril—Body temperature increased—Doxorubicin—peripheral nervous system neoplasm	8.23e-05	0.000318	CcSEcCtD
Captopril—ALB—Transmembrane transport of small molecules—COX2—peripheral nervous system neoplasm	8.1e-05	0.000825	CbGpPWpGaD
Captopril—Asthenia—Epirubicin—peripheral nervous system neoplasm	8.08e-05	0.000312	CcSEcCtD
Captopril—Pruritus—Epirubicin—peripheral nervous system neoplasm	7.96e-05	0.000307	CcSEcCtD
Captopril—MMP9—Signaling Pathways—PPP3R1—peripheral nervous system neoplasm	7.85e-05	0.000799	CbGpPWpGaD
Captopril—MMP9—Axon guidance—NRAS—peripheral nervous system neoplasm	7.77e-05	0.000791	CbGpPWpGaD
Captopril—Diarrhoea—Epirubicin—peripheral nervous system neoplasm	7.7e-05	0.000297	CcSEcCtD
Captopril—ABCB1—Allograft Rejection—CASP3—peripheral nervous system neoplasm	7.69e-05	0.000783	CbGpPWpGaD
Captopril—ABCB1—Integrated Pancreatic Cancer Pathway—BDNF—peripheral nervous system neoplasm	7.6e-05	0.000773	CbGpPWpGaD
Captopril—ALB—FOXA2 and FOXA3 transcription factor networks—AKT1—peripheral nervous system neoplasm	7.59e-05	0.000773	CbGpPWpGaD
Captopril—Asthenia—Doxorubicin—peripheral nervous system neoplasm	7.47e-05	0.000288	CcSEcCtD
Captopril—Dizziness—Epirubicin—peripheral nervous system neoplasm	7.44e-05	0.000287	CcSEcCtD
Captopril—ABCB1—Metabolism—PPIP5K2—peripheral nervous system neoplasm	7.38e-05	0.000751	CbGpPWpGaD
Captopril—Pruritus—Doxorubicin—peripheral nervous system neoplasm	7.37e-05	0.000284	CcSEcCtD
Captopril—ALB—Platelet activation, signaling and aggregation—HGF—peripheral nervous system neoplasm	7.37e-05	0.00075	CbGpPWpGaD
Captopril—MMP9—Developmental Biology—ERBB2—peripheral nervous system neoplasm	7.28e-05	0.000742	CbGpPWpGaD
Captopril—F2—GPCR downstream signaling—KNG1—peripheral nervous system neoplasm	7.26e-05	0.000739	CbGpPWpGaD
Captopril—Vomiting—Epirubicin—peripheral nervous system neoplasm	7.16e-05	0.000276	CcSEcCtD
Captopril—Diarrhoea—Doxorubicin—peripheral nervous system neoplasm	7.13e-05	0.000275	CcSEcCtD
Captopril—ABCB1—Transmembrane transport of small molecules—COX2—peripheral nervous system neoplasm	7.1e-05	0.000723	CbGpPWpGaD
Captopril—Rash—Epirubicin—peripheral nervous system neoplasm	7.1e-05	0.000274	CcSEcCtD
Captopril—Dermatitis—Epirubicin—peripheral nervous system neoplasm	7.09e-05	0.000273	CcSEcCtD
Captopril—Headache—Epirubicin—peripheral nervous system neoplasm	7.05e-05	0.000272	CcSEcCtD
Captopril—F2—Hemostasis—PTPN11—peripheral nervous system neoplasm	6.98e-05	0.000711	CbGpPWpGaD
Captopril—CYP2D6—Metabolism—PPIP5K2—peripheral nervous system neoplasm	6.95e-05	0.000708	CbGpPWpGaD
Captopril—Dizziness—Doxorubicin—peripheral nervous system neoplasm	6.89e-05	0.000266	CcSEcCtD
Captopril—Nausea—Epirubicin—peripheral nervous system neoplasm	6.69e-05	0.000258	CcSEcCtD
Captopril—SLC22A6—Transmembrane transport of small molecules—GNAS—peripheral nervous system neoplasm	6.64e-05	0.000676	CbGpPWpGaD
Captopril—Vomiting—Doxorubicin—peripheral nervous system neoplasm	6.62e-05	0.000255	CcSEcCtD
Captopril—F2—Signaling by GPCR—KNG1—peripheral nervous system neoplasm	6.59e-05	0.000671	CbGpPWpGaD
Captopril—F2—Signaling Pathways—VIP—peripheral nervous system neoplasm	6.57e-05	0.000669	CbGpPWpGaD
Captopril—Rash—Doxorubicin—peripheral nervous system neoplasm	6.57e-05	0.000253	CcSEcCtD
Captopril—Dermatitis—Doxorubicin—peripheral nervous system neoplasm	6.56e-05	0.000253	CcSEcCtD
Captopril—Headache—Doxorubicin—peripheral nervous system neoplasm	6.52e-05	0.000252	CcSEcCtD
Captopril—SLC22A6—Transmembrane transport of small molecules—ABCB1—peripheral nervous system neoplasm	6.51e-05	0.000663	CbGpPWpGaD
Captopril—ALB—Folate Metabolism—TP53—peripheral nervous system neoplasm	6.5e-05	0.000662	CbGpPWpGaD
Captopril—F2—GPCR downstream signaling—GNAS—peripheral nervous system neoplasm	6.35e-05	0.000646	CbGpPWpGaD
Captopril—Nausea—Doxorubicin—peripheral nervous system neoplasm	6.19e-05	0.000239	CcSEcCtD
Captopril—MMP2—Developmental Biology—HRAS—peripheral nervous system neoplasm	6.18e-05	0.000629	CbGpPWpGaD
Captopril—F2—Gastrin-CREB signalling pathway via PKC and MAPK—HRAS—peripheral nervous system neoplasm	6.09e-05	0.00062	CbGpPWpGaD
Captopril—F2—Signaling Pathways—PPP3R1—peripheral nervous system neoplasm	6.06e-05	0.000617	CbGpPWpGaD
Captopril—MMP9—Signaling Pathways—NTRK2—peripheral nervous system neoplasm	5.9e-05	0.0006	CbGpPWpGaD
Captopril—F2—Signaling by GPCR—GNAS—peripheral nervous system neoplasm	5.76e-05	0.000587	CbGpPWpGaD
Captopril—ALB—Metabolism—HSD17B12—peripheral nervous system neoplasm	5.69e-05	0.000579	CbGpPWpGaD
Captopril—MMP9—Axon guidance—HRAS—peripheral nervous system neoplasm	5.68e-05	0.000578	CbGpPWpGaD
Captopril—MMP9—Developmental Biology—NRAS—peripheral nervous system neoplasm	5.54e-05	0.000564	CbGpPWpGaD
Captopril—MMP2—Developmental Biology—AKT1—peripheral nervous system neoplasm	5.46e-05	0.000556	CbGpPWpGaD
Captopril—LTA4H—Metabolism—AKT1—peripheral nervous system neoplasm	5.27e-05	0.000537	CbGpPWpGaD
Captopril—F2—Platelet activation, signaling and aggregation—AKT1—peripheral nervous system neoplasm	5.26e-05	0.000535	CbGpPWpGaD
Captopril—MMP9—Signaling Pathways—KNG1—peripheral nervous system neoplasm	5.04e-05	0.000513	CbGpPWpGaD
Captopril—ABCB1—Metabolism—HSD17B12—peripheral nervous system neoplasm	4.98e-05	0.000507	CbGpPWpGaD
Captopril—ALB—Hemostasis—IFNB1—peripheral nervous system neoplasm	4.92e-05	0.000501	CbGpPWpGaD
Captopril—ABCB1—HIF-1-alpha transcription factor network—AKT1—peripheral nervous system neoplasm	4.81e-05	0.00049	CbGpPWpGaD
Captopril—MMP9—Signaling Pathways—NTRK1—peripheral nervous system neoplasm	4.81e-05	0.000489	CbGpPWpGaD
Captopril—ALB—Metabolism of lipids and lipoproteins—BCHE—peripheral nervous system neoplasm	4.73e-05	0.000481	CbGpPWpGaD
Captopril—CYP2D6—Metabolism—HSD17B12—peripheral nervous system neoplasm	4.7e-05	0.000478	CbGpPWpGaD
Captopril—ALB—Hemostasis—KNG1—peripheral nervous system neoplasm	4.56e-05	0.000464	CbGpPWpGaD
Captopril—F2—Signaling Pathways—NTRK2—peripheral nervous system neoplasm	4.55e-05	0.000463	CbGpPWpGaD
Captopril—MMP9—Signaling Pathways—GNAS—peripheral nervous system neoplasm	4.41e-05	0.000449	CbGpPWpGaD
Captopril—ALB—Transmembrane transport of small molecules—SLC2A1—peripheral nervous system neoplasm	4.29e-05	0.000437	CbGpPWpGaD
Captopril—F2—Hemostasis—NRAS—peripheral nervous system neoplasm	4.2e-05	0.000427	CbGpPWpGaD
Captopril—ABCB1—Integrated Pancreatic Cancer Pathway—ERBB2—peripheral nervous system neoplasm	4.18e-05	0.000426	CbGpPWpGaD
Captopril—ALB—Metabolism—GNS—peripheral nervous system neoplasm	4.11e-05	0.000419	CbGpPWpGaD
Captopril—MMP9—Developmental Biology—HRAS—peripheral nervous system neoplasm	4.05e-05	0.000413	CbGpPWpGaD
Captopril—F2—Signaling by GPCR—PTPN11—peripheral nervous system neoplasm	4.01e-05	0.000408	CbGpPWpGaD
Captopril—ALB—Hemostasis—GNAS—peripheral nervous system neoplasm	3.99e-05	0.000406	CbGpPWpGaD
Captopril—ALB—Metabolism—NME1—peripheral nervous system neoplasm	3.94e-05	0.000401	CbGpPWpGaD
Captopril—F2—Signaling Pathways—KNG1—peripheral nervous system neoplasm	3.89e-05	0.000396	CbGpPWpGaD
Captopril—ALB—Hemostasis—HGF—peripheral nervous system neoplasm	3.8e-05	0.000387	CbGpPWpGaD
Captopril—ABCB1—Integrated Pancreatic Cancer Pathway—CASP3—peripheral nervous system neoplasm	3.8e-05	0.000386	CbGpPWpGaD
Captopril—ALB—Metabolism—COX2—peripheral nervous system neoplasm	3.8e-05	0.000386	CbGpPWpGaD
Captopril—ABCB1—Transmembrane transport of small molecules—SLC2A1—peripheral nervous system neoplasm	3.76e-05	0.000383	CbGpPWpGaD
Captopril—F2—Signaling Pathways—NTRK1—peripheral nervous system neoplasm	3.71e-05	0.000378	CbGpPWpGaD
Captopril—ABCB1—Metabolism—GNS—peripheral nervous system neoplasm	3.6e-05	0.000367	CbGpPWpGaD
Captopril—MMP9—Developmental Biology—AKT1—peripheral nervous system neoplasm	3.58e-05	0.000364	CbGpPWpGaD
Captopril—ABCB1—Metabolism—NME1—peripheral nervous system neoplasm	3.45e-05	0.000352	CbGpPWpGaD
Captopril—ALB—Transmembrane transport of small molecules—GNAS—peripheral nervous system neoplasm	3.45e-05	0.000351	CbGpPWpGaD
Captopril—F2—Signaling Pathways—GNAS—peripheral nervous system neoplasm	3.41e-05	0.000347	CbGpPWpGaD
Captopril—CYP2D6—Metabolism—GNS—peripheral nervous system neoplasm	3.4e-05	0.000346	CbGpPWpGaD
Captopril—ALB—Transmembrane transport of small molecules—ABCB1—peripheral nervous system neoplasm	3.39e-05	0.000345	CbGpPWpGaD
Captopril—ABCB1—Metabolism—COX2—peripheral nervous system neoplasm	3.33e-05	0.000339	CbGpPWpGaD
Captopril—CYP2D6—Metabolism—NME1—peripheral nervous system neoplasm	3.26e-05	0.000331	CbGpPWpGaD
Captopril—F2—Hemostasis—TP53—peripheral nervous system neoplasm	3.21e-05	0.000327	CbGpPWpGaD
Captopril—CYP2D6—Metabolism—COX2—peripheral nervous system neoplasm	3.13e-05	0.000319	CbGpPWpGaD
Captopril—F2—Hemostasis—HRAS—peripheral nervous system neoplasm	3.07e-05	0.000313	CbGpPWpGaD
Captopril—MMP9—Signaling Pathways—PTPN11—peripheral nervous system neoplasm	3.07e-05	0.000312	CbGpPWpGaD
Captopril—ABCB1—Transmembrane transport of small molecules—GNAS—peripheral nervous system neoplasm	3.02e-05	0.000308	CbGpPWpGaD
Captopril—ABCB1—Integrated Pancreatic Cancer Pathway—MYC—peripheral nervous system neoplasm	2.96e-05	0.000302	CbGpPWpGaD
Captopril—ALB—Hemostasis—PTPN11—peripheral nervous system neoplasm	2.77e-05	0.000282	CbGpPWpGaD
Captopril—F2—Hemostasis—AKT1—peripheral nervous system neoplasm	2.71e-05	0.000276	CbGpPWpGaD
Captopril—ALB—Metabolism—ENO2—peripheral nervous system neoplasm	2.49e-05	0.000254	CbGpPWpGaD
Captopril—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—peripheral nervous system neoplasm	2.43e-05	0.000248	CbGpPWpGaD
Captopril—MMP9—Signaling Pathways—ERBB2—peripheral nervous system neoplasm	2.42e-05	0.000247	CbGpPWpGaD
Captopril—F2—Signaling by GPCR—NRAS—peripheral nervous system neoplasm	2.41e-05	0.000245	CbGpPWpGaD
Captopril—F2—Signaling Pathways—PTPN11—peripheral nervous system neoplasm	2.37e-05	0.000241	CbGpPWpGaD
Captopril—MMP9—Signaling Pathways—CASP3—peripheral nervous system neoplasm	2.2e-05	0.000224	CbGpPWpGaD
Captopril—ABCB1—Metabolism—ENO2—peripheral nervous system neoplasm	2.18e-05	0.000222	CbGpPWpGaD
Captopril—ALB—Metabolism—BCHE—peripheral nervous system neoplasm	2.11e-05	0.000214	CbGpPWpGaD
Captopril—ALB—Platelet activation, signaling and aggregation—AKT1—peripheral nervous system neoplasm	2.09e-05	0.000212	CbGpPWpGaD
Captopril—CYP2D6—Metabolism—ENO2—peripheral nervous system neoplasm	2.06e-05	0.000209	CbGpPWpGaD
Captopril—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—peripheral nervous system neoplasm	2.06e-05	0.000209	CbGpPWpGaD
Captopril—ALB—Metabolism—SLC2A1—peripheral nervous system neoplasm	2.01e-05	0.000204	CbGpPWpGaD
Captopril—ALB—Metabolism—TH—peripheral nervous system neoplasm	1.98e-05	0.000202	CbGpPWpGaD
Captopril—F2—Signaling Pathways—ERBB2—peripheral nervous system neoplasm	1.87e-05	0.00019	CbGpPWpGaD
Captopril—ABCB1—Metabolism—BCHE—peripheral nervous system neoplasm	1.84e-05	0.000188	CbGpPWpGaD
Captopril—MMP9—Signaling Pathways—NRAS—peripheral nervous system neoplasm	1.84e-05	0.000188	CbGpPWpGaD
Captopril—F2—Signaling by GPCR—HRAS—peripheral nervous system neoplasm	1.76e-05	0.000179	CbGpPWpGaD
Captopril—ABCB1—Metabolism—SLC2A1—peripheral nervous system neoplasm	1.76e-05	0.000179	CbGpPWpGaD
Captopril—CYP2D6—Metabolism—BCHE—peripheral nervous system neoplasm	1.74e-05	0.000177	CbGpPWpGaD
Captopril—ABCB1—Metabolism—TH—peripheral nervous system neoplasm	1.73e-05	0.000177	CbGpPWpGaD
Captopril—MMP9—Signaling Pathways—MYC—peripheral nervous system neoplasm	1.72e-05	0.000175	CbGpPWpGaD
Captopril—F2—GPCR downstream signaling—AKT1—peripheral nervous system neoplasm	1.71e-05	0.000174	CbGpPWpGaD
Captopril—F2—Signaling Pathways—CASP3—peripheral nervous system neoplasm	1.7e-05	0.000173	CbGpPWpGaD
Captopril—ALB—Hemostasis—NRAS—peripheral nervous system neoplasm	1.67e-05	0.00017	CbGpPWpGaD
Captopril—CYP2D6—Metabolism—SLC2A1—peripheral nervous system neoplasm	1.66e-05	0.000169	CbGpPWpGaD
Captopril—CYP2D6—Metabolism—TH—peripheral nervous system neoplasm	1.63e-05	0.000166	CbGpPWpGaD
Captopril—ALB—Metabolism—GNAS—peripheral nervous system neoplasm	1.62e-05	0.000165	CbGpPWpGaD
Captopril—ALB—Metabolism—ABCB1—peripheral nervous system neoplasm	1.59e-05	0.000161	CbGpPWpGaD
Captopril—F2—Signaling by GPCR—AKT1—peripheral nervous system neoplasm	1.56e-05	0.000158	CbGpPWpGaD
Captopril—F2—Signaling Pathways—NRAS—peripheral nervous system neoplasm	1.42e-05	0.000145	CbGpPWpGaD
Captopril—ABCB1—Metabolism—GNAS—peripheral nervous system neoplasm	1.42e-05	0.000144	CbGpPWpGaD
Captopril—MMP9—Signaling Pathways—TP53—peripheral nervous system neoplasm	1.41e-05	0.000144	CbGpPWpGaD
Captopril—MMP9—Signaling Pathways—HRAS—peripheral nervous system neoplasm	1.35e-05	0.000137	CbGpPWpGaD
Captopril—CYP2D6—Metabolism—GNAS—peripheral nervous system neoplasm	1.33e-05	0.000136	CbGpPWpGaD
Captopril—F2—Signaling Pathways—MYC—peripheral nervous system neoplasm	1.33e-05	0.000135	CbGpPWpGaD
Captopril—CYP2D6—Metabolism—ABCB1—peripheral nervous system neoplasm	1.31e-05	0.000133	CbGpPWpGaD
Captopril—ALB—Hemostasis—TP53—peripheral nervous system neoplasm	1.27e-05	0.00013	CbGpPWpGaD
Captopril—ALB—Hemostasis—HRAS—peripheral nervous system neoplasm	1.22e-05	0.000124	CbGpPWpGaD
Captopril—MMP9—Signaling Pathways—AKT1—peripheral nervous system neoplasm	1.19e-05	0.000121	CbGpPWpGaD
Captopril—F2—Signaling Pathways—TP53—peripheral nervous system neoplasm	1.09e-05	0.000111	CbGpPWpGaD
Captopril—ALB—Hemostasis—AKT1—peripheral nervous system neoplasm	1.08e-05	0.00011	CbGpPWpGaD
Captopril—F2—Signaling Pathways—HRAS—peripheral nervous system neoplasm	1.04e-05	0.000106	CbGpPWpGaD
Captopril—F2—Signaling Pathways—AKT1—peripheral nervous system neoplasm	9.19e-06	9.36e-05	CbGpPWpGaD
Captopril—ALB—Metabolism—AKT1—peripheral nervous system neoplasm	4.36e-06	4.44e-05	CbGpPWpGaD
Captopril—ABCB1—Metabolism—AKT1—peripheral nervous system neoplasm	3.82e-06	3.89e-05	CbGpPWpGaD
Captopril—CYP2D6—Metabolism—AKT1—peripheral nervous system neoplasm	3.6e-06	3.67e-05	CbGpPWpGaD
